Nutritional care before and after surgery for head and neck cancer
Official title: Improvement of the Nutritional Course of Care After Surgical Treatment at the Patients Affected by a Cancer of the Head and by the Neck
Run by Centre Hospitalier Universitaire, Amiens · NCT03632200 · Data updated 2026-11-12
This project will see if a more intensive nutrition program before and after surgery helps adults having head and neck cancer keep weight and recover better than usual care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Centre Hospitalier Universitaire, Amiens Academic / other |
| Locations | 1 site (Amiens) |
| Status | Recruiting |
| Started | March 21, 2019 |
| Main results expected | September 2027 |
| Study ends | September 2027 |
| Registry record updated | May 13, 2026 |
| Trial ID | NCT03632200 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (age 18+) undergoing surgery for head and neck cancer who can give written consent and are covered by a national insurance scheme are ideal candidates.
✕Probably not a fit
Patients who are minors, under guardianship, receiving radiotherapy, or already enrolled in other nutrition studies are not eligible and would not benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a two-group interventional comparison of standard SFNEP-based nutritional care versus an enhanced nutritional program for adults undergoing surgery for head and neck cancer. The enhanced program provides preoperative dietary advice in a multidisciplinary consultation and structured postoperative dietetic follow-up (a dietetic visit at hospital discharge day 7 plus phone calls at months 1, 2, 4 and 5), with monthly multidisciplinary visits for undernourished patients for six months. The control group is managed according to current SFNEP recommendations (personalized dietary advice and oral nutritional supplements preoperatively, with no specific postoperative protocol). Eligible adult patients are enrolled at CHU Amiens-Picardie and patients receiving radiotherapy, minors, those under guardianship, or participants in other nutrition research are excluded.
Why it matters
Potential benefit: If successful, the enhanced program could reduce postoperative weight loss and improve nutritional recovery after head and neck cancer surgery.
How similar studies have gone: Previous studies of perioperative nutrition and oral supplements in head and neck cancer have reported improvements in weight and outcomes, but structured postoperative individualized programs like this are less well studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients affected by a cancer of the VADS * Man or woman of 18 and more years old * Patient benefiting from a surgery for its cancer of the VADS * Patient having signed a written consent * Patient member in a national insurance scheme Exclusion Criteria: * Patient minor * Patient benefiting from a radiotherapy * Patient participant in another research interfering on the nutritional state of the patient * Patients under guardianship or guardianship
Where it's running
-
CHU Amiens-Picardie
Amiens, France Recruiting
Study contacts
- Principal investigator: Stéphanie Dakpé, MD — CHU Amiens Picardie
- Study coordinator: Stéphanie Dakpé, MD
- Email: dakpe.stephanie@chu-amiens.fr
- Phone: +330322089080
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Phenotype-based Pain Guidance for Head and Neck Cancer-Related Pain (pilot)
This pilot test sees if tailoring pain treatment to a patient’s pain type can reduce head and neck cancer pain in adults who haven’t started cancer treatment yet.
-
Airway ultrasound in head and neck cancer patients
This observational study tests whether neck ultrasound measurements of the airway match CT measurements in adults with maxillofacial cancer undergoing surgery with anesthesia.
-
Safe use of metformin and naproxen to help prevent cancer in people with Fanconi anemia
This study tests whether metformin and naproxen can lower the chance of cancer developing in adults with Fanconi anemia.
-
Iparomlimab and Tuvonralimab With Cetuximab Before Surgery in Resectable Oral Cancer
In this phase 2 study, patients with locally advanced, resectable oral squamous cell carcinoma will receive a combination of iparomlimab, tuvonralimab, and cetuximab before surgery to see if the treatment is safe and can shrink tumors.
-
SumMET: Targeted radioligand therapy for c-MET–positive solid tumors
This first‑in‑human study tests the safety and potential effectiveness of a radioligand therapy called [225Ac]Ac-FL-261 in adults with advanced or metastatic solid tumors that overexpress c-MET.
-
Using Silverlon for head and neck patients with tracheostomies
This early-phase study tests whether Silverlon dressings can prevent severe skin reactions under tracheostomy collars in adults with head and neck cancer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.